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Ultrasound-guided angioplasty of autogenous
arteriovenous fistulas in the office setting
Daniel R. Gorin, MD, FACS,a Lisa Perrino, RDMS, RVT,a Donna M. Potter, RN, MS, ANP-BC,b and
Tarik Z. Ali, BS,b Hyannis, Mass; and The Bottom, Saba, The Netherlands
Objective:There has been an increasing awareness of the superiority of native arteriovenous fistulas (AVFs) over prosthetic
grafts for dialysis access. Many AVFs fail to mature, however, and others develop stenosis while in use. There is growing
experience in treating these patients in the interventional suite with percutaneous balloon angioplasty. These procedures,
however, are expensive, uncomfortable, and inconvenient for patients and physicians, and involve exposure to radiation
and intravenous contrast in patients who are often not on dialysis. This study reviews our experience with ultrasound-
guided angioplasty of AVFs in the office setting.
Methods: A retrospective review was performed of all patients treated in our practice with ultrasound-guided AVF
angioplasty, from May 2009 to April 2011. The need for intervention was determined by examination and duplex
ultrasound. All patients referred to the practice with failing or nonmaturing AVFs were treated in the office under
ultrasound guidance, unless a central venous stenosis was suspected. All procedures were performed with the patient
under local anesthesia by a single surgeon, and preprocedure, periprocedure, and postprocedure ultrasounds were
performed in a single vascular laboratory.
Results: There were 31 AVFs in 30 patients in the study. Fifty-five interventions were performed, 48 for AVFs failing to
mature and seven for stenosis in functioning AFVs. The 90-day patency was 93%. The overall complication rate was 11%.
Two patients had proximal stenosis that could not be crossed (one patient required surgical revision and one patient
refused further treatment and thrombosed). There were four perifistular hematomas; three of these resulted in AFV
thrombosis. No patients required hospitalization or urgent surgical intervention. Eighty-five percent of patients treated
for AVF failing to mature achieved a functional fistula.
Conclusions: AVF intervention can be performed safely and effectively under ultrasound guidance in the office setting and
is a valuable tool in the management of dialysis access patients. ( J Vasc Surg 2012;55:1701-5.)
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MTwo factors have combined to create a significant
change in dialysis access management over the past decade.
The first is an increasing awareness of the superiority of
native arteriovenous fistulas (AVFs) as the dialysis access of
choice.1 According to the Fistula First Breakthrough Ini-
tiative database,2 the prevalence of AVF use in patients on
dialysis increased from 32.2% in July 2003 to 58% in June
2011. While still short of the Fistula First Breakthrough
Initiative’s goal of 66%,3 this represents a marked change in
the standard of care in patients on dialysis. As part of this
change, there has been an increasing utilization of endovas-
cular interventions to create and maintain native AVFs.4-6
The second factor has been a move to shift endovascu-
lar procedures from the hospital to an ambulatory setting.7
This has been influenced by a number of factors, most
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ialysis access intervention is particularly suited to an office
nvironment. The procedures are usually fairly straightfor-
ard, equipment needs are modest and predictable, the
essels to be treated are superficial, and most importantly,
ccess site management is much simpler and safer. For
atients, procedures performed in the office are almost
lways more convenient and less stressful, and, for the
ealth care system, they are much less expensive. One
mpediment to treating these patients in the office, how-
ver, has been the need for imaging equipment, which
reates issues of space requirements, radiation safety, and
xpense.
We have found that performing dialysis access interven-
ions under duplex ultrasound guidance can circumvent
hese concerns. The vascular lesions that require treatment
re readily imaged with ultrasound, and the needed equip-
ent is readily available in most vascular surgeons’ offices.
ver the past several years, we have adopted duplex-
uided, office-based angioplasty as our primary mode of
ndovascular intervention in our dialysis access patients. In
his series, we present our initial experience with this tech-
ique.
ETHODS
Starting in May 2009, we began treating all of our
atients undergoing percutaneous angioplasty of autoge-
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Patients were only treated in the hospital interventional
unit if they were undergoing treatment of a suspected
central vein stenosis because of significant arm swelling or
inadequate fistula flow in the absence of flow-limiting le-
sions on ultrasound. This occurred in only one patient
during the study period. FromMay 2009 to April 2011, we
performed a total 55 percutaneous angioplasties on 31
autogenous AVFs in 30 patients (14 women; 16 men;
average age, 73 years). The fistulas treated were Cimino
(17; 55%), upper arm cephalic (nine; 29%), and basilic
transposition (five; 16%). Forty-eight (87%) of the inter-
ventions were performed on fistulas that had failed to
mature, and seven (13%) were done on fistulas that devel-
oped hemodynamically significant stenoses while they were
being used. An average of 1.7 interventions were per-
formed on each fistula during the time of the study. The
time from fistula creation until the initial intervention
ranged from 52 to 3304 days (median, 120 days). Forty-
three percent of the patients (13 of 30) were undergoing
hemodialysis via a temporary dialysis catheter at the time of
their interventions.
The decision to intervene on a fistula was based on the
National Kidney Foundation Kidney Disease Outcomes
Quality Initiative guidelines.8 Clinical and ultrasound eval-
uation, as well as flow rates for those fistulas currently being
used for hemodialysis, were used in the assessments. The
“rule of 6s” was used as a benchmark: fistulas should be 6
mm in diameter, 6 mm or less from the skin, and ready for
use in 6 weeks. Inadequate flowwas defined as less than 400
to 500 mL/minute and was measured using the on-line
clearance technique. All of the fistulas that were treated
because they had failed to mature were treated because of
inadequate size. These fistulas also invariably had areas of
discrete stenosis identified by ultrasound evaluation. These
stenoses were further displayed during treatment in which
clearly visualized “waists” in the angioplasty balloons were
seen, which resolved as the stenoses were treated.
TECHNIQUE
A single operating surgeon performed all of the proce-
dures. Patients were treated in a procedure room in a
freestanding medical office building. The procedures were
done with the patients under local anesthesia; no additional
sedation was used and the patients were not kept on NPO.
Patients were prepped and draped in the usual sterile man-
ner. Both the surgeon and the vascular ultrasound technol-
ogist were gowned and gloved, and the ultrasound key-
board was covered with a clear sterile drape (Fig 1). The
fistula was then examined by ultrasound and the areas to be
treated were identified. This was done using a Phillips
(Amsterdam, The Netherlands) Ultramark HDI 3000 du-
plex ultrasound machine with linear array 10 to 5 and 12 to
6 probes. Access was obtained using a micropuncture tech-
nique under ultrasound guidance. Fistulas were accessed
retrograde (34; 62%), antegrade (18; 33%), or dual access
(3; 5%), depending upon the anatomy and the location of
the stenosis. An appropriately sized sheath, 11 cm, 4 to 7Fr, oas placed over a short J wire. A 0.035-angled Zipwire
Boston Scientific, Natick, Mass) was directed through the
stula under ultrasound guidance, using a short Berenstein
atheter (Boston Scientific) if needed. Heparin (3000 u)
as only used early in our experience; the majority of
atients were treated without anticoagulation with the
xception of heparin flushes of the access sheath. An Ultra-
hin-Diamond angioplasty balloon (Boston Scientific) was
hen directed over the guidewire and positioned appropri-
tely (Fig 2). Balloons were sized at 1 to 2 mm larger than
he normal vein size and ranged from 4 to 12 mm in
iameter, with lengths of 4 to 10 cm. Our first few patients
xperienced discomfort with balloon inflation. We then
odified our technique. Under ultrasound guidance, a
umescent anesthetic solution (28 mL of 1% lidocaine with
pinephrine and 10 mL of sodium bicarbonate in 250 mL
ig 1. Room set up for ultrasound-guided arteriovenous fistula
AVF) intervention.
ig 2. The guidewire and angioplasty balloon can be clearly
isualized under ultrasound, allowing for precise placement and
reatment.f normal saline) was infiltrated along the length of the
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Volume 55, Number 6 Gorin et al 1703fistula using a 21-gauge spinal needle (Fig 3). This was
tolerated very well and made the angioplasties essentially
painless. Angioplasties were done at fairly high pressures
of 20 to 30 atms, with balloon inflation times of approx-
imately 1 minute (Fig 4, A and B). Selective manual
inflow occlusion was performed, particularly if longer
sclerotic segments were being treated. Once a comple-
tion ultrasound demonstrated a satisfactory result (Fig
5), the sheath was removed and a figure of eight suture
was placed with manual inflow occlusion. A gentle pres-
sure dressing was applied and the patient was discharged
after a brief period of observation. Patients were seen
for follow-up ultrasound and examination in 2 weeks
(Fig 6).
RESULTS
There were a total of six complications (11%). Two pa-
tients had proximal stenoses that could not be crossed under
ultrasound guidance. One of these patients had an upper arm
cephalic fistula and underwent fistulography in the hospital
interventional unit where the stenosis still could not be
crossed. She was successfully treated in the operating room
with patch angioplasty. The second patient had a Cimino
fistula. She refused further intervention and re-presented a
month later with a thrombosed fistula. She went on to have
successful creation of a transposition fistula.
Small perifistula hematomas were not uncommon and
were not counted as complications. There were four inci-
dences of significant hematomas (in three patients). One
patient had a large hematoma after angioplasty that was con-
trolled with pressure and resolved, resulting in a functioning
fistula. One patient developed significant hematomas on two
different occasions after angioplasty of two different fistulas.
First, he underwent treatment of a long sclerotic segment in a
basilic transposition fistulawith angioplasty to 6mm, resulting
in vein rupture, hematoma, and subsequent fistula thrombo-
sis. He later had a contralateral upper arm cephalic fistula
Fig 3. Tumescent anesthesia is injected along the length of the
area to be treated using ultrasound guidance.created, which developed a long proximal sclerotic segment, which was treated with angioplasty to 6 mm, also resulting in
ein rupture and thrombosis. He went on to have an upper
rm prosthetic fistula placed, which worked well. The last
atient underwent treatment of a proximal stenosis via retro-
rade access in a basilic transposition fistula. She then devel-
ped a perifistula hematoma. A distal stenosis was then iden-
ified that had not been appreciated initially. Antegrade access
as obtained and the stenosis was treated with manual inflow
cclusion; however, the patient had developed a fairly large
ematoma and went on to thrombose her fistula.
All patients, with the exception of the four mentioned
bove, had patent fistulas at 30 and 90 days, resulting in a
0-day patency rate of 93%. All four fistulas that thrombosed
ig 4. A and B, The “waist” can be clearly visualized as the
alloon is inflated and a stenosis is treated.ere small nonfunctioning fistulas that had failed to mature.
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mature, 22 of 27 developed functional fistulas (81.4%). An
additional patient had a patent AVF but expired before his last
planned intervention. Therefore, 85% of fistulas (22 of 26)
treated to completion were functional. All seven of the inter-
ventions done for a hemodynamically significant stenosis in
fistulas currently in use resulted in a functional AVF.
All complications were easily managed in the office
setting. No patient required transfer to the hospital, blood
transfusion, or subsequent hospitalization or emergency
room evaluation for complications of their procedure. No
patient underwent successful intervention in the interven-
tional suite after unsuccessful treatment under ultrasound
Fig 5. Completion ultrasound commonly shows small intralumi-
nal abnormalities but confirms a widely patent arteriovenous fistula
(AVF) with no flow-limiting lesions. These abnormalities are
found to have resolved on follow-up ultrasound.
Fig 6. An example of a large forearm cephalic arterioven-
ous fistula (AVF) created from a small vein with several high-
grade stenosis that were treated with ultrasound-guided
angioplasty.guidance. lISCUSSION
There are several small series in the literature of ultrasound-
uided angioplasty of dialysis access AVFs. In 2007, Marks et
l9 presented a small series of 10 patients treated with ultra-
ound guidance performed in the operating room. All of the
rocedures were successfully completed under ultrasound
uidance, although one patient had a completion angiogram
onfirming the ultrasound findings. Four patients required
utting balloons and in one patient a self-expanding stent was
laced as well. All fistulas were patent in 30 days. In 2009, the
ame group published a larger series of 32 interventions on 25
atients done under ultrasound guidance in the office setting.
hey had one hematoma and one focal dissection, with no
eriprocedural thrombosis and no serious complications. No
atient required a stent or the use of a cutting balloon or other
djunctive modalities.
Kim et al10 presented a series of 10 selected patients who
nderwent ultrasound-guided interventions in the angiogra-
hy suite from September 2006 to February 2007. The pa-
ients were treated with a single ultrasound-guided angio-
lasty and then underwent a completion angiogram. Two
atients were found to have residual stenosis by angiography
nd underwent further angioplasty. One of these was also
ecognized by ultrasound, and the secondwas not seen due to
he very short nature of the stenosis.
Fox et al11 presented a series of 223 consecutive office-
ased duplex-guided AVF angioplasties performed from
anuary 2008 to June 2009. Cutting balloons were re-
uired in three cases; one uncovered stent was placed for
lastic recoil, and four covered stents were placed for fistula
upture or pseudoaneurysm formation.
Our series similarly shows office-based ultrasound-guided
ngioplasty of AVFs to be safe and effective.Wedid have three
eriprocedural thromboses related to graft rupture. Two of
hese occurred in a single patient with long sclerotic segments
n two different small, nonfunctional fistulas. It does not seem
ikely that these outcomes would have been prevented by the
se of fluoroscopic imaging. The stenoses were well visual-
zed, and the balloons chosen were fairly small (6 mm).
erhaps these fistulas could have been salvaged with place-
ent of covered stents, but it is difficult to see how that would
ave resulted in a functional, durable access. The patient had
lacement of a prosthetic graft which has functioned well.
One patient complication could be interpreted as oc-
urring because of limits of our imagining; the patient that
eveloped a hematoma in part because of a distal stenosis
hat was not well appreciated. This occurred early in our
xperience. The patient was treated on heparin which con-
ributed to the hematoma; we no longer anticoagulate our
atients. The distal stenosis was well seen during the initial
ltrasound, but its significance was underestimated. Cur-
ently, we are more facile with manual proximal occlusion
echniques, we do not use systemic heparin, and we are
ore attuned to treating distal stenosis before treating
roximal lesions, so this type of complication is much less
ikely to occur in the future. Treating a patient in the
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Volume 55, Number 6 Gorin et al 1705interventional suite under fluoroscopic guidance would
realistically have prevented no other complication.
Using ultrasound guidance for intervention on AVFs
offers a number of advantages. It uses equipment that is
relatively inexpensive and readily available. It avoids the
problems associated with radiation exposure for both pa-
tients and treating clinicians. It also eliminates the need for
contrast agents, which is particularly helpful as many of
these patients have severe impairment of renal function but
are not yet on dialysis. With ultrasound guidance, tumes-
cent anesthesia can be infiltrated along the areas of the
fistula to be treated, making the procedure very comfort-
able and eliminating the need for conscious sedation.
The use of ultrasound as the imaging modality also
removes a major barrier to performing these procedures in
the office setting. Fluoroscopic imaging equipment is ex-
pensive and occupies a great deal of space. Unless one is
doing full-time dialysis access management or performing
other fluoroscopic-guided procedures, such as angiogra-
phy, arterial intervention, or painmanagement, it is difficult
to justify the expense of setting up an office-based fluoros-
copy suite. Radiation safety and local and regional regula-
tory issues add even more complexity. Ultrasound equip-
ment is readily available in most vascular surgeons’ offices.
It is relatively inexpensive and used in a variety of other
related applications, such as diagnostic vascular imaging
and venous intervention. It is also necessary for complete
dialysis access management, both in planning surgical pro-
cedures to create dialysis access fistulas as well as for diag-
nosis and follow-up of AVF malfunctions.
Moving dialysis access interventions to the office provides
a number of advantages to both physician and patient. For
patients, the office setting is much more convenient. Those
already on dialysis have to devote 3 days a week to their
medical care and often have other health issues that occupy
even more of their time. The complexity of a hospital system
invariably means that procedures done there take up most of
the day. When these procedures are done in the office, most
patients are in and out in less than an hour. Because no
conscious sedation is used, the patients donot have to fast, and
no intravenous access or preoperative blood work is needed.
For the physician, the office environment is much more effi-
cient and allows them much greater control of personnel and
scheduling issues. Because the vascular sonographer is in-
volved in the procedures, he or she becomesmuchmore adept
at preoperative and postoperative diagnostic imaging, and the
entire office staff becomesmuchmore knowledgeable regard-
ing management issues in these patients.
Office-based dialysis access intervention provides significant
financial advantages aswell.Because theCenter forMedicare and
Medicaid Services has recognized the cost savings that can be
realized by moving these procedures out of the hospital, they
have provided significant financial incentives. The Current Pro-
cedure Terminology codes for angioplasty and AVF are 35478
(repair of a venous blockage), 36147 (access of dialysis graft for
evaluation), and 75978 to 26 (radiologic supervision and inter-
pretation). In our region, the reimbursement is $387.39 when
the procedure is done in the hospital. When the procedure is Serformed in an office setting, the reimbursement is $2375.80,
ore than a sixfold increase. Even when the cost of equipment
nd personnel is taken into account, this still represents a signifi-
ant financial advantage.
ONCLUSIONS
Duplex ultrasound-guided angioplasty of AVFs in the
ffice setting is feasible, safe, and effective. It offers a
umber of advantages over hospital-based, fluoroscopic
rocedures, and, in the future, has great potential to play a
ignificant role in the management of these challenging
atients.
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